This molecular feature defined a major characteristic of diffuse astrocytic and oligodendroglial tumors: IDH-mutant gliomas are associated with distinct biology and favorable clinical outcomes, whereas IDH-wildtype gliomas share genomic aberrations and clinical behavior with glioblastomas [4]. The gene discussed is IDH2; the disease is glioma.